New hope for breast cancer survivors: laser and gel may ease vaginal atrophy without hormones
NCT ID NCT05585476
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tests whether a CO2 laser combined with a regenerative gel can relieve vaginal atrophy symptoms—like dryness, pain, and itching—in 180 breast cancer survivors who cannot use hormone therapy. Participants will be randomly assigned to receive the laser plus gel, laser alone, or gel alone. The goal is to improve quality of life and reduce discomfort without hormones.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- CO2 laser and regenerative topical gel
- What this could lead to
- If it works, this could offer a safe, non-hormonal option to relieve painful vaginal symptoms in breast cancer survivors.
- What could go wrong
- This is an early-stage trial with no phase assigned, so results are uncertain. The laser and gel may not provide lasting relief, and biopsies are involved.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Can a personalized exercise program boost recovery in cancer survivors?
- Smartwatch could spot nerve damage before it starts
- Could ionized gas help fight breast cancer after surgery?
- Radiation may let breast cancer patients keep their nipple
- Can a smart digital program restore sleep for cancer survivors?